Infinity Pharmaceuticals | INFI - Loan Capital


Infinity Pharmaceuticals reported $0 in Loan Capital for its fiscal quarter ending in June of 2022.





Loan Capital Change Date
AbbVie USD 62.97B 12M Sep/2025
Alterity Therapeutics Limited AUD 103.21K 73.88K Jun/2023
Amgen USD 50B 2.43B Dec/2025
AstraZeneca USD 26.14B 19.58B Dec/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
Cipla INR 2.98B 454.6M Sep/2025
Clal Biotechnology ILS 25.96M 18.48M Dec/2023
Compugen USD 0 0 Dec/2024
CSL USD 10.69B 1.37B Jun/2025
Eisai JPY 134.77B 12M Dec/2025
Eli Lilly USD 40.87B 5.6M Dec/2025
Gilead Sciences USD 22.14B 5M Sep/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
Grifols EUR 10.67B 564.4M Sep/2025
Incyte USD 30.2M 5.17M Dec/2025
Infinity Pharmaceuticals USD 0 0 Jun/2022
Ionis Pharmaceuticals USD 28.78M 596.71M Sep/2025
J&J USD 39.44B 30M Dec/2025
Novartis USD 24.24B 174M Sep/2025
Pfizer USD 57.41B 93M Sep/2025
Plus Therapeutics USD 3.79M 322K Dec/2022
Roche Holding CHF 27.43B 966M Dec/2025
TG Therapeutics USD 245.34M 303K Sep/2025